oxazoles has been researched along with Kahler Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, R; Cowled, MS; Lacey, E; Lacey, H; Piggott, AM; Rutledge, PJ; Vuong, D | 1 |
| Alcaro, S; Arbitrio, M; Ascrizzi, S; Barraja, P; Barreca, M; Caracciolo, D; Di Martino, MT; Grillone, K; Juli, G; Maruca, A; Montalbano, A; Polerà, N; Riillo, C; Rocca, R; Scionti, F; Spanò, V; Tagliaferri, P; Tassone, P | 1 |
| Apewokin, SK; Mathur, P; Matin, A; Sharma, S | 1 |
| Arkin, MR; Conroy, A; Fox, JA; Hawtin, RE; Hoch, U; Stockett, DE; Walker, D | 1 |
| Badros, AZ; Chen, R; Chen, T; Coutre, S; Fox, JA; Harvey, RD; Hoch, U; Kegley, P; Mahadocon, K; Plunkett, W; Popplewell, L; Siegel, D; Sinha, R; Tong, WG; Wierda, WG | 1 |
| Dasgupta, R; Doudican, NA; Mazumder, A; Narayanan, BA; Narayanan, NK; Park, J; Xu, D | 1 |
| Anderson, KC; Hurley, LH; Koley, H; Li, C; Munshi, NC; Shammas, MA; Shmookler Reis, RJ | 1 |
2 trial(s) available for oxazoles and Kahler Disease
| Article | Year |
|---|---|
SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Oxazoles; Protein Kinase Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Thiazoles | 2009 |
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myeloma.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 9; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Oxazoles; Survival Rate; Thiazoles; Tissue Distribution; Treatment Outcome | 2010 |
5 other study(ies) available for oxazoles and Kahler Disease
| Article | Year |
|---|---|
Yeppoonic acids A - D: 1,2,4-trisubstituted arene carboxylic acid co-metabolites of conglobatin from an Australian Streptomyces sp.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Australia; Carboxylic Acids; Cell Line, Tumor; Humans; Male; Mice; Multiple Myeloma; Oxazoles; Prostatic Neoplasms; Queensland; Soil Microbiology; Streptomyces | 2022 |
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Calreticulin; Cell Line, Tumor; Colchicine; Humans; Immunogenic Cell Death; Isoindoles; Microtubules; Multiple Myeloma; Oxazoles; Pemetrexed; Taxoids; Vinca Alkaloids | 2022 |
Myelosuppression-sparing treatment of central nervous system nocardiosis in a multiple myeloma patient utilizing a tedizolid-based regimen: a case report.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Brain; Central Nervous System Infections; Debridement; Female; Florida; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Multiple Myeloma; Nocardia; Nocardia Infections; Organophosphates; Oxazoles; Treatment Outcome | 2017 |
Antagonistic effect of small-molecule inhibitors of Wnt/β-catenin in multiple myeloma.
Topics: Antineoplastic Agents; beta Catenin; Blotting, Western; Cell Line, Tumor; Cell Movement; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique; Humans; Multiple Myeloma; Oxazoles; Real-Time Polymerase Chain Reaction; Signal Transduction; Thiazoles; Transfection; Vascular Endothelial Growth Factor A; Wnt Proteins | 2012 |
Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma.
Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; DNA Repair; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Multiple Myeloma; Oligonucleotide Array Sequence Analysis; Oxazoles; Recombination, Genetic; Telomerase; Telomere; Time Factors | 2004 |